<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">14908</article-id><article-id pub-id-type="doi">10.7554/eLife.14908</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>mTORC1 is necessary but mTORC2 and GSK3β are inhibitory for AKT3-induced axon regeneration in the central nervous system</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-40357"><name><surname>Miao</surname><given-names>Linqing</given-names></name><aff><institution content-type="dept">Shriners Hospitals Pediatric Research Center</institution>, <institution>Temple University Lewis Katz School of Medicine</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40358"><name><surname>Yang</surname><given-names>Liu</given-names></name><aff><institution content-type="dept">Shriners Hospitals Pediatric Research Center</institution>, <institution>Temple University Lewis Katz School of Medicine</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40359"><name><surname>Huang</surname><given-names>Haoliang</given-names></name><aff><institution content-type="dept">Shriners Hospitals Pediatric Research Center</institution>, <institution>Temple University Lewis Katz School of Medicine</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40360"><name><surname>Liang</surname><given-names>Feisi</given-names></name><aff><institution content-type="dept">Shriners Hospitals Pediatric Research Center</institution>, <institution>Temple University Lewis Katz School of Medicine</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-40361"><name><surname>Ling</surname><given-names>Chen</given-names></name><aff><institution content-type="dept">Division of Cellular and Molecular Therapy, Department of Pediatrics</institution>, <institution>University of Florida College of Medicine</institution>, <addr-line><named-content content-type="city">Gainesville</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-40043"><name><surname>Hu</surname><given-names>Yang</given-names></name><aff><institution content-type="dept">Shriners Hospitals Pediatric Research Center</institution>, <institution>Temple University Lewis Katz School of Medicine</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country><email>yanghu@temple.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1184"><name><surname>Sonenberg</surname><given-names>Nahum</given-names></name><role>Reviewing editor</role><aff><institution>McGill University</institution>, <country>Canada</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>03</month><year>2016</year></pub-date><elocation-id>e14908</elocation-id><supplementary-material><ext-link xlink:href="elife-14908-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>01</day><month>02</month><year>2016</year></date><date date-type="accepted"><day>21</day><month>03</month><year>2016</year></date></history><permissions><copyright-statement>© 2016, Miao et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Miao et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Injured mature CNS axons do not regenerate in mammals. Deletion of PTEN, the negative regulator of PI3K, induces CNS axon regeneration through activation of PI3K-mTOR signaling. We have conducted an extensive molecular dissection of the cross-regulating mechanisms in axon regeneration that involve the downstream effectors of PI3K, AKT and the two mTOR complexes (mTORC1 and mTORC2). We found that the predominant AKT isoform in CNS, AKT3, induces much more robust axon regeneration than AKT1 and that activation of mTORC1 and inhibition of GSK3β are two critical parallel pathways for AKT-induced axon regeneration. Surprisingly, phosphorylation of T308 and S473 of AKT play opposite roles in GSK3β phosphorylation and inhibition, by which mTORC2 and pAKT-S473 negatively regulate axon regeneration. Thus our study revealed a complex neuron-intrinsic balancing mechanism involving AKT as the nodal point of PI3K, mTORC1/2 and GSK3β that coordinates both positive and negative cues to regulate adult CNS axon regeneration.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#4351) of the Temple University School of Medicine.</p></fn></fn-group></back></article>